NAFDAC launches GreenBook, Traceability Project, and Pediatric Policy to curb substandard medical products, ensuring safer healthcare for Nigerians
[dropcap]T[/dropcap]he National Agency for Food and Drug Administration and Control (NAFDAC) has launched three groundbreaking initiatives — GreenBook, Traceability Project, and Pediatric Policy — aimed at curbing counterfeit and substandard medical products in Nigeria.
Also read: NAFDAC alerts public about counterfeit Phesgo injection batch in Nigeria
Announced during a stakeholder sensitization meeting in the Northwest Zone, NAFDAC’s Director-General, Prof. Mojisola Adeyeye, represented by Mr. Bitrus Fraden, explained the role of each initiative.
The GreenBook serves as a consumer tool to identify potentially fake products, the Traceability Project ensures legal tracking of products across the supply chain, and the Pediatric Regulation 2024 addresses children’s unique medical needs.
“With these technologies, stakeholders can better detect and prevent the entry of fake products into the supply chain,” Adeyeye said, highlighting the agency’s commitment to using modern methods to mitigate counterfeiters’ increasingly sophisticated tactics.
The workshop brought together healthcare providers, manufacturers, and wholesalers for training on these tools.
NAFDAC also urged sector stakeholders to support the fight against fake medical products to ensure Nigerians have access to safe, quality, and effective healthcare.
Also read: NAFDAC warns of counterfeit malaria drug circulating in Nigeria
The event saw participation from key healthcare bodies, including the Pharmacy Council of Nigeria, the Association of Medical Laboratory Scientists, and the Nigerian Association of Patent and Proprietary Medicine Dealers (NAPPMED).
